A. Berruti

Annals of Oncology · 2006–2020

A researcher in the Science corpus: 5 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from A. Berruti's perspective

Ordered by how strongly the researchers A. Berruti trusts endorse each paper. Same corpus, a different order for every researcher.

  1. European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium. (European Journal of Endocrinology)
  2. Extent of Surgery Affects Survival for Papillary Thyroid Cancer (Annals of Surgery)
  3. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. (Journal of Clinical Endocrinology and Metabolism)
  4. Sorafenib in locally advanced or metastatic, radioactive iodine-refractory, differentiated thyroid cancer: a randomized, double-blind, phase 3 trial (The Lancet)
  5. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. (New England Journal of Medicine)
  6. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). (European Journal of Cancer)
  7. Guidelines for radioiodine therapy of differentiated thyroid cancer (European Journal of Nuclear Medicine and Molecular Imaging)
  8. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. (New England Journal of Medicine)
  9. Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial. (Journal of Clinical Oncology)
  10. The changing incidence of thyroid cancer (Nature Reviews Endocrinology)

Their papers